1210 related articles for article (PubMed ID: 33723017)
21. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.
Yamada S; Noda T; Okabe K; Yanagida S; Nishida M; Kanda Y
J Pharmacol Sci; 2022 Jul; 149(3):139-146. PubMed ID: 35641026
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey EE; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33811184
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
24. Change of gene expression profiles in human cardiomyocytes and macrophages infected with SARS
Yang Y; Wang S; Xie X; Li J; Zhang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Nov; 46(11):1203-1211. PubMed ID: 34911854
[TBL] [Abstract][Full Text] [Related]
25. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells.
Rockwood SJ; Arzt M; Sharma A
Curr Cardiol Rep; 2022 Dec; 24(12):2121-2129. PubMed ID: 36272051
[TBL] [Abstract][Full Text] [Related]
26. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.
Sharma A; Garcia G; Wang Y; Plummer JT; Morizono K; Arumugaswami V; Svendsen CN
Cell Rep Med; 2020 Jul; 1(4):100052. PubMed ID: 32835305
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Expression of VDR in Myocardium: Postmortem Evaluation of COVID-19 Patients.
Kriventsov MA; Yermola YA; Davydova AA; Beketov AA; Makalish TP; Zyablitskaya EY; Geraschenko AV; Kubyshkin AV; Galyshevskaya AA; Zausalina AI
J Histochem Cytochem; 2022 May; 70(5):391-399. PubMed ID: 35357255
[TBL] [Abstract][Full Text] [Related]
28. Cardiac pathology in COVID-19: a single center autopsy experience.
Sang CJ; Burkett A; Heindl B; Litovsky SH; Prabhu SD; Benson PV; Rajapreyar I
Cardiovasc Pathol; 2021; 54():107370. PubMed ID: 34273507
[TBL] [Abstract][Full Text] [Related]
29. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
Amendola A; Garoffolo G; Songia P; Nardacci R; Ferrari S; Bernava G; Canzano P; Myasoedova V; Colavita F; Castilletti C; Sberna G; Capobianchi MR; Piacentini M; Agrifoglio M; Colombo GI; Poggio P; Pesce M
Cardiovasc Res; 2021 May; 117(6):1557-1566. PubMed ID: 33705542
[TBL] [Abstract][Full Text] [Related]
30. Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2.
Yang L; Nilsson-Payant BE; Han Y; Jaffré F; Zhu J; Wang P; Zhang T; Redmond D; Houghton S; Møller R; Hoagland D; Carrau L; Horiuchi S; Goff M; Lim JK; Bram Y; Richardson C; Chandar V; Borczuk A; Huang Y; Xiang J; Ho DD; Schwartz RE; tenOever BR; Evans T; Chen S
Stem Cell Reports; 2021 Sep; 16(9):2274-2288. PubMed ID: 34403650
[TBL] [Abstract][Full Text] [Related]
31. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails.
Yiangou L; Davis RP; Mummery CL
Stem Cell Reports; 2021 Mar; 16(3):385-397. PubMed ID: 33306986
[TBL] [Abstract][Full Text] [Related]
32. Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection.
Sharma A; Garcia G; Arumugaswami V; Svendsen CN
bioRxiv; 2020 Apr; ():. PubMed ID: 32511402
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril.
Huang X; Fan W; Sun J; Yang J; Zhang Y; Wang Q; Li P; Zhang Y; Zhang S; Li H; Wang J; Feng L; Zhao J; Chen L; Qu L
Antiviral Res; 2023 Jul; 215():105636. PubMed ID: 37207821
[TBL] [Abstract][Full Text] [Related]
34. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
[TBL] [Abstract][Full Text] [Related]
35. Human Induced Pluripotent Stem Cell-Derived Lung Epithelial System for SARS-CoV-2 Infection Modeling and Its Potential in Drug Repurposing.
Surendran H; Nandakumar S; Pal R
Stem Cells Dev; 2020 Nov; 29(21):1365-1369. PubMed ID: 32867617
[TBL] [Abstract][Full Text] [Related]
36. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
Xie LM; Huang YF; Liu YL; Liang JQ; Deng W; Lin GL; Luo HM; Guo XG
Biochem Genet; 2022 Dec; 60(6):2052-2068. PubMed ID: 35235083
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium.
Zhang R; Chen X; Zuo W; Ji Z; Qu Y; Su Y; Yang M; Zuo P; Ma G; Li Y
Bioengineered; 2022 Feb; 13(2):2486-2497. PubMed ID: 35037831
[TBL] [Abstract][Full Text] [Related]
38. Sars-Cov-2 Spike Protein-Induced Damage of hiPSC-Derived Cardiomyocytes.
Huang X; Huang B; He Y; Feng L; Shi J; Wang L; Peng J; Chen Y
Adv Biol (Weinh); 2022 Jul; 6(7):e2101327. PubMed ID: 35523737
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
40. Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.
Pellegrini D; Kawakami R; Guagliumi G; Sakamoto A; Kawai K; Gianatti A; Nasr A; Kutys R; Guo L; Cornelissen A; Faggi L; Mori M; Sato Y; Pescetelli I; Brivio M; Romero M; Virmani R; Finn AV
Circulation; 2021 Mar; 143(10):1031-1042. PubMed ID: 33480806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
